Female Sexual Dysfunction in Peritoneal Dialysis and Hemodialysis Patients

Basit Öğe Kaydı
dc.contributor.authorYazıcı, Raziye
dc.contributor.authorAltıntepe, Lütfullah
dc.contributor.authorGüney, İbrahim
dc.contributor.authorYeksan, Mehdi
dc.contributor.authorAtalay, Hüseyin
dc.contributor.authorTürk, Süleyman
dc.contributor.authorTonbul, Halil Zeki
dc.date.accessioned2020-03-26T17:38:43Z
dc.date.available2020-03-26T17:38:43Z
dc.date.issued2009
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractBackground. Sexual dysfunction (SD) is a common problem in end-stage renal disease (ESRD). In contrast to basic and clinical research in the field of male SD, the sexual problems of women have received relatively little attention and are often under-treated. We evaluated sexual function in female ESRD patients using the validated Female Sexual Function Index (FSFI) and relation with QOL, depression, and some laboratory parameters. Methods. 117 ESRD patients (85 peritoneal dialysis [PD], 32 hemodialysis [HD], mean age 48.5 +/- 13.9 years) were enrolled. All patients had been dialyzed (PD or HD) for more than three months. In addition, an age-matched married control group of 48 subjects (mean age 47.1 +/- 12.7 years) were enrolled in the study. All patients were asked to complete three questionnaires of the FSFI, Beck Depression Index (BDI) and SF-36. Results. Female sexual dysfunction was found in 80 of the 85 peritoneal dialysis patients (94.1%) and all of the HD patients (100%), but in only 22 subjects of the control group (45.8%). A significant negative correlation was found between total FSFI score and age (r = -0.288, p = 0.002), BDI score (r = -0.471, p < 0.001), mental-physical component score of QOL (r = -0.463, p < 0.001 and r = -0.491, p < 0.001, respectively) in PD and HD patients. The rates of depression were 75.3, 43.8, and 4.2% in the PD and HD patients and control subjects, respectively. Conclusion. Female sexual dysfunction is common problem ESRD. This problem especially related with depression and QOL. Thus, sexual function should be evaluated in female subjects to determine its impact on quality of life.en_US
dc.identifier.doi10.1080/08860220902883012en_US
dc.identifier.endpage364en_US
dc.identifier.issn0886-022Xen_US
dc.identifier.issn1525-6049en_US
dc.identifier.issue5en_US
dc.identifier.pmid19839835en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage360en_US
dc.identifier.urihttps://dx.doi.org/10.1080/08860220902883012
dc.identifier.urihttps://hdl.handle.net/20.500.12395/23554
dc.identifier.volume31en_US
dc.identifier.wosWOS:000268583200005en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherTAYLOR & FRANCIS LTDen_US
dc.relation.ispartofRENAL FAILUREen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectdepressionen_US
dc.subjectfemale sexual dysfunctionen_US
dc.subjecthemodialysisen_US
dc.subjectperitoneal dialysisen_US
dc.titleFemale Sexual Dysfunction in Peritoneal Dialysis and Hemodialysis Patientsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu